RESEARCHER PROFILE

Peter John Barnes

← Back to Imperial College London

P

Imperial College London

Asthma and respiratory diseasesChronic Obstructive Pulmonary Disease (COPD) ResearchInhalation and Respiratory Drug DeliveryOccupational exposure and asthmaNeuropeptides and Animal Physiology

Peter John Barnes works in Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Inhalation and Respiratory Drug Delivery, Occupational exposure and asthma, Neuropeptides and Animal Physiology. Recorded institutional associations include Imperial College London.

2,411Publications
220,371Citations
217H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

    2012 · 15,993 citations
  2. Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases

    1997 · 4,669 citations
  3. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

    2007 · 4,664 citations
  4. Global strategy for asthma management and prevention: GINA executive summary

    2007 · 3,199 citations
  5. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary

    2017 · 3,180 citations
  6. Sex and gender: modifiers of health, disease, and medicine

    2020 · 1,978 citations
  7. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019

    2019 · 1,937 citations
  8. Systemic manifestations and comorbidities of COPD

    2009 · 1,820 citations
  9. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response

    2000 · 1,814 citations
  10. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease

    2016 · 1,683 citations
  11. Anti-inflammatory Actions of Glucocorticoids: Molecular Mechanisms

    1998 · 1,582 citations
  12. Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma

    1997 · 1,520 citations
  13. Chronic obstructive pulmonary disease: molecular and cellularmechanisms

    2003 · 1,439 citations
  14. Increased nitric oxide in exhaled air of asthmatic patients

    1994 · 1,436 citations
  15. Immunology of asthma and chronic obstructive pulmonary disease

    2008 · 1,399 citations
  16. Chronic obstructive pulmonary disease in non-smokers

    2009 · 1,368 citations
  17. Differences in Interleukin-8 and Tumor Necrosis Factor-Alpha in Induced Sputum From Patients With Chronic Obstructive Pulmonary Disease or Asthma

    1996 · 1,362 citations
  18. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary

    2023 · 1,303 citations
  19. Exhaled breath condensate: methodological recommendations and unresolved questions

    2005 · 1,280 citations
  20. Chronic Obstructive Pulmonary Disease

    2000 · 1,080 citations
  21. The cytokine network in asthma and chronic obstructive pulmonary disease

    2008 · 982 citations
  22. Glucocorticoid resistance in inflammatory diseases

    2009 · 982 citations
  23. Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease

    2005 · 968 citations
  24. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary

    2017 · 881 citations
  25. Outcomes for COPD pharmacological trials: from lung function to biomarkers

    2008 · 858 citations

← Return to the university profile